New drug combo shows promise for tough childhood cancer
NCT ID NCT06341998
First seen Sep 30, 2025 · Last updated May 17, 2026 · Updated 29 times
Summary
This study tested a new treatment for children with a rare and hard-to-treat cancer called yolk sac tumor that had come back or not responded to standard chemotherapy. The treatment combined the drug sirolimus with a three-drug chemotherapy regimen. The goal was to see if this combination could shrink tumors and improve survival. The study involved 32 children aged 18 or younger.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Cancer Hospital and Institute
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.